Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide ; volume:8 ; number:2 ; day:3 ; month:10 ; year:2011 ; pages:1 ; date:12.2011
Retrovirology ; 8, Heft 2 (3.10.2011), 1, 12.2011
- Creator
-
Férir, Geoffrey
- Contributor
-
Palmer, Kenneth E.
Schols, Dominique
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-8-S2-O36
- URN
-
urn:nbn:de:1111-2016080720144
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Férir, Geoffrey
- Palmer, Kenneth E.
- Schols, Dominique
- SpringerLink (Online service)
Other Objects (12)
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study
Model-based anti-HIV therapy
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood
The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
Anti-HIV nucleosides : past, present and future
Anti-HIV and immune modulating activities of IND02
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Semi-supervised learning for predicting anti-HIV drug resistance
Anti-HIV activity of drugs that stimulate cholesterol efflux
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study
Model-based anti-HIV therapy
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood
The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
Anti-HIV nucleosides : past, present and future
Anti-HIV and immune modulating activities of IND02
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Semi-supervised learning for predicting anti-HIV drug resistance
Anti-HIV activity of drugs that stimulate cholesterol efflux
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study
Model-based anti-HIV therapy
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood
The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
Anti-HIV nucleosides : past, present and future
Anti-HIV and immune modulating activities of IND02
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Semi-supervised learning for predicting anti-HIV drug resistance